MedTrace Logo

Adjuvant to General Anesthesia in Patients Undergoing Major Abdominal Surgeries

NCT03600493 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2018-08-03

No results posted yet for this study

Summary

assessing the effect of perioperative infusion of Dexmedetomidine versus Lidocaine on neuro endocrine stress response to surgery and anesthesia

Conditions

  • Stress Related Disorder

Interventions

DRUG

Dexmedetomidine

Dexmedetomidine 1 mcg/kg over 10 min followed by 0.4 mcg/kg/hr. till the start of wound closure.

DRUG

Lidocaine

Lidocaine given as 1mg/kg over 10 min followed by 1mg/kg/hr till the start of wound closure.

Sponsors & Collaborators

  • Suez Canal University

    lead OTHER

Principal Investigators

  • Mohamed A Elsadany, MD · Anesthesia and Intesive Care department, Faculty of Medicine, Suez Canal University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-31
Primary Completion
2019-03-31
Completion
2019-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03600493 on ClinicalTrials.gov